More interestingly, uterine corpus endometrial carcinoma displayed lower median transcriptional levels of CDK6 than normal tissues (p < 0.001) (data not shown), suggesting that malignancy displays high heterogeneity, and it is practical to evaluate IHC staining of CDK6 in these entities for precision therapy. The gene discussed is CDK6; the disease is uterine corpus endometrial carcinoma.